Scott Rocklage earned a Bachelor of Science (BS) in chemistry from the University of California at Berkeley and a Doctor of Philosophy (PhD) in chemistry from the Massachusetts Institute of Technology (MIT). Dr. Rocklage has been utilizing his education in the healthcare field for more than 30 years. He has many years of leadership in the field and is responsible for getting drug candidates into clinical trials.

Scott Rocklage has taken on Chairman and Chief Executive Officer (CEO) challenges at Cubist Pharmaceuticals, CEO and President of Nycomed Salutar along with a variety of research and design (R&D) positions at Salutar and Catalytica.

In 2003, Scott Rocklage joined at 5AM Ventures. He began his career at 5AM Ventures as a venture partner and the next year became the Managing Partner. The company is a life science based venture capital firm and takes on the early stage of a business and 5AM is considered early in the day.

Rocklage and his company works with entrepreneurs who are physicians, scientists or business executives. He helps them work on shaping ideas into medicines to meet the needs of the medical community.

He takes great pride in being part of the growth of medications being used to treat cancer in offbeat ways. The trend so far is saving and extending lives while improvements are already on the forefront to do greater things.

Rocklage also takes pride in being very organized and considers time management one of his greatest tools. He prioritizes his work and works through his list of tasks to accomplish in order, completing a task before moving on.

As an entrepreneur, Rocklage is not afraid to take measured risks. He finds he does his best work by working for himself than working for an established company. He has greater control over the final product and the steps it takes to get there.

He advises others to stay true to your business and its strengths. Venturing too far from strengths often ends with doing what is easy rather than doing what is right. He also acknowledges failure is part of the success equation and it is necessary to analyze a failure and make corrections immediately before moving on.

Learn more about Scott Rocklage:

http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift
http://people.equilar.com/bio/scott-rocklage-cidara-therapeutics-/salary/913398#.WWaMA9PytTY